MERIT MEDICAL SYSTEMS INC
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
MMSI$88.42+1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · · · Incorporated by Reference · | |||||||||
| Exhibit No. | | Description | | Form | | Exhibit | | Filing Date | |
| 3.1 | | Second Amended and Restated Articles of Incorporation.* | | 10-Q | | 3.1 | | August 9, 2018 | |
| 3.2 | | Fifth Amended and Restated Bylaws of Merit Medical Systems, Inc.* | | 8-K | | 3.1 | | May 19, 2026 | |
| 10.1 | | Form of Indemnification Agreement, dated July 17, 2026, between Merit Medical Systems, Inc. and each director.† | | — | | — | | — | |
| 10.2 | | Form of Indemnification Agreement, dated July 17, 2026, between Merit Medical Systems, Inc. and each of the following individuals: Raul Parra, Brian G. Lloyd, Christian Adam Smith and Michel J. Voigt.† | | — | | — | | — | |
| 10.3 | | Employment Agreement, effective as of August 31, 2026, between Merit Medical Systems, Inc. and Sheri L. Lewis.*† | | 8-K | | 10.1 | | August 20, 2026 | |
| 10.4 | | Indemnification Agreement, dated August 31, 2026, between Merit Medical Systems, Inc. and Sheri L. Lewis.† | | — | | — | | — | |
| 31.1 | | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | | — | | — | | — | |
| 31.2 | | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | | — | | — | | — | |
| 32.1 | | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | | — | | — | | — | |
| 32.2 | | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | | — | | — | | — | |
| 101 | | The following financial information from the quarterly report on Form 10-Q for the quarter ended September 30, 2026, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) related Condensed Notes to the Unaudited Consolidated Financial Statements, tagged in detail. | | — | | — | | — | |
| 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document). | | — | | — | | — | | |
- These exhibits are incorporated herein by reference.
† Indicates management contract or compensatory plan or arrangement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.